Obesity often leads to
obesity-related
cardiac hypertrophy (ORCH), which is suppressed by
zinc-induced inactivation of
p38 mitogen-activated protein kinase (
p38 MAPK). In this study, we investigated the mechanisms by which
zinc inactivates
p38 MAPK to prevent ORCH. Mice (4-week old) were fed either high fat diet (HFD, 60% kcal fat) or normal diet (ND, 10% kcal fat) containing variable amounts of
zinc (deficiency, normal and supplement) for 3 and 6 months.
P38 MAPK siRNA and the
p38 MAPK inhibitor
SB203580 were used to suppress
p38 MAPK activity in vitro and in vivo, respectively. HFD activated
p38 MAPK and increased expression of
B-cell lymphoma/CLL 10 (BCL10) and caspase recruitment domain family member 9 (CARD9). These responses were enhanced by
zinc deficiency and attenuated by
zinc supplement. Administration of
SB203580 to HFD mice or specific
siRNA in
palmitate-treated cardiomyocytes eliminated the HFD and
zinc deficiency activation of
p38 MAPK, but did not significantly impact the expression of BCL10 and CARD9. In cultured cardiomyocytes, inhibition of BCL10 expression by
siRNA prevented
palmitate-induced increased
p38 MAPK activation and
atrial natriuretic peptide (
ANP) expression. In contrast, inhibition of
p38 MAPK prevented
ANP expression, but did not affect BCL10 expression. Deletion of
metallothionein abolished the protective effect of
zinc on
palmitate-induced up-regulation of BCL10 and phospho-p38 MAPK. HFD and
zinc deficiency synergistically induce ORCH by increasing oxidative stress-mediated activation of BCL10/CARD9/
p38 MAPK signalling.
Zinc supplement ameliorates ORCH through activation of
metallothionein to repress oxidative stress-activated BCL10 expression and
p38 MAPK activation.